Literature DB >> 31524721

Acute kidney injury in hematopoietic stem cell transplantation.

Rimda Wanchoo1, Brian R Stotter2, Ruthee L Bayer3, Kenar D Jhaveri1.   

Abstract

PURPOSE OF REVIEW: Acute kidney injury (AKI) in the setting of hematopoietic stem cell transplantation (HSCT) is common in pediatric and adult patients. The incidence ranges from 12 to 66%, and development of AKI in the posttransplant course is independently associated with higher mortality. RECENT
FINDINGS: Patients who undergo HSCT have many risk factors for developing AKI, including sepsis, use of nephrotoxic medications, graft versus host disease (GVHD), and veno-occlusive disease (VOD). In addition, engraftment syndrome/cytokine storm, transplant-associated thrombotic microangiopathy (TA-TMA), and less common infections with specific renal manifestations, such as BK and adenovirus nephritis, may lead to kidney injury. There has been significant advancement in the understanding of TA-TMA in particular, especially the role of the complement system in its pathophysiology. The role of early dialysis has been explored in the pediatric population, but not well studied in adult HSCT recipients
SUMMARY: This review provides an update on the risk factors, causes, and treatment approaches to HSCT-associated AKI.

Entities:  

Year:  2019        PMID: 31524721     DOI: 10.1097/MCC.0000000000000657

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  6 in total

1.  Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy.

Authors:  Jeremy D Rubinstein; Xiang Zhu; Carolyn Lutzko; Tom Leemhuis; Jose A Cancelas; Sonata Jodele; Catherine M Bollard; Patrick J Hanley; Stella M Davies; Michael S Grimley; Adam S Nelson
Journal:  Blood Adv       Date:  2020-07-28

2.  Incidence and mortality of acute kidney injury in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis.

Authors:  S R Kanduri; W Cheungpasitporn; C Thongprayoon; T Bathini; K Kovvuru; V Garla; J Medaura; P Vaitla; K B Kashani
Journal:  QJM       Date:  2020-09-01

Review 3.  Acute kidney injury in cancer patients.

Authors:  Shuiying Liu; Jinyuan Zhao; Feng Wang
Journal:  Clin Exp Nephrol       Date:  2021-09-09       Impact factor: 2.801

4.  Acute Tubulointerstitial Nephritis in Clinical Oncology: A Comprehensive Review.

Authors:  Laura Martínez-Valenzuela; Juliana Draibe; Xavier Fulladosa; Montserrat Gomà; Francisco Gómez; Paula Antón; Josep María Cruzado; Joan Torras
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

5.  Incidence and Risk Factors for Acute Kidney Injury after Allogeneic Stem Cell Transplantation: A Prospective Study.

Authors:  Andreea Andronesi; Bogdan Sorohan; Andreea Burcea; Lavinia Lipan; Cristina Stanescu; Oana Craciun; Laura Stefan; Adela Ranete; Zsofia Varady; Oana Ungureanu; Gabriela Lupusoru; Gabriela Agrigoroaei; Danut Andronesi; Luminita Iliuta; Bogdan Obrisca; Alina Tanase
Journal:  Biomedicines       Date:  2022-01-25

Review 6.  Recent Advances of Acute Kidney Injury in Hematopoietic Cell Transplantation.

Authors:  Masahiro Miyata; Kazunobu Ichikawa; Eri Matsuki; Masafumi Watanabe; Daniel Peltier; Tomomi Toubai
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.